Treatment Options for Vascular Malformations in the Brain

Diagnostic Evaluation

Digital subtraction angiography (DSA) is the gold standard for pre-treatment assessment of cerebral vascular malformations, providing superior spatial and temporal resolution for identifying angioarchitectural features, and 2D, 3D, and reformatted cross-sectional views are recommended 1, 4
MRI and MRA provide complementary information, with better soft tissue resolution for assessing relationship to eloquent brain regions, but are less sensitive than DSA for detecting small feeding vessels and nidus characteristics 3, 4
CT angiography shows 90% sensitivity for overall AVM detection, 100% for AVMs >3 cm 3

Microsurgical resection is the most validated approach for complete removal of AVM nidus, offering immediate elimination of hemorrhage risk, and best outcomes are seen with low-grade AVMs (Spetzler-Martin grades I and II) 4, 5
Endovascular embolization should be performed in the context of a complete multidisciplinary treatment plan aiming for AVM obliteration and cure, with primary roles including pre-surgical adjunct to reduce intraoperative blood loss and surgical complexity, targeted embolization of high-risk features in ruptured AVMs to reduce rebleeding risk, and palliative treatment for symptomatic AVMs when curative therapy is not possible 2, 5
Stereotactic radiosurgery (SRS) is a viable option for inoperable AVMs, with gradual obliteration over 2-3 years following treatment, but the role of AVM embolization as an adjunct to radiosurgery is not well-established 2

For Arteriovenous Malformations, small, superficial, non-eloquent AVMs (Spetzler-Martin grades I-II): Microsurgical resection is preferred, while medium-sized or deep AVMs may require a combined approach with pre-operative embolization followed by surgery, and large, complex, or eloquent AVMs may require a multimodal approach or stereotactic radiosurgery 2, 4, 5

Imaging follow-up after apparent cure is recommended to assess for recurrence, with DSA remaining the gold standard for detecting residual or recurrent AVMs, and non-invasive imaging may be used for longitudinal follow-up in stable cases 2
Complete obliteration is essential as subtotal treatment does not provide protection from future complications, and long-term follow-up is critical as recurrence can occur even years after apparent cure 2, 5
The American College of Radiology suggests that treatment decisions should prioritize mortality and morbidity outcomes, and that the ARUBA trial suggested medical management alone was superior to interventional therapy for unruptured brain AVMs, but this remains controversial 1, 2, 3